Published 23 days ago • loading... • Updated 23 days ago

EURETINA: PulseSight Therapeutics to Present Results of Phase 1 clinical trial of PST-611 treatment for dry AMD/Geographic Atrophy (GA)

Summary by WBOC 16

Late Breaking Oral Presentation at 26th EURETINA Congress, 1-4 October 2026, Vienna

1 Articles

WBOC 16

Center

EURETINA: PulseSight Therapeutics to Present Results of Phase 1 clinical trial of PST-611 treatment for dry AMD/Geographic Atrophy (GA)

Late Breaking Oral Presentation at 26th EURETINA Congress, 1-4 October 2026, Vienna

23 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left0Leaning Right0Center1Last Updated22 days agoBias Distribution

100% Center

Bias Distribution

100% of the sources are Center

100% Center

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

WBOC 16 broke the news 23 days ago on Wednesday, September 16, 2026.

Sources are mostly out of (0)

EURETINA: PulseSight Therapeutics to Present Results of Phase 1 clinical trial of PST-611 treatment for dry AMD/Geographic Atrophy (GA)

1 Articles

1 Articles

EURETINA: PulseSight Therapeutics to Present Results of Phase 1 clinical trial of PST-611 treatment for dry AMD/Geographic Atrophy (GA)

Coverage Details

Bias Distribution

Factuality

Ownership

More stories like this

Microsoft event debuts new AI-friendly hardware and Windows changes

Trump's AI Science Push Gets $100 Million Boost From a Computing Power Donation

AMD To Bring FSR4 To Gaming Handhelds By End Of 2026

Arista Announces Rack-Scale Architectures for Scale-Up and Scale-Out AI Fabrics

HPE Launches Four New AMD-Powered Servers as Part of Its ProLiant Gen13 Portfolio

ASUS Zenbook 14 (UX3480) Philippines Launch: New Colors, Specs, and Price

Similar News Topics

Similar News Topics

More stories like this

Microsoft event debuts new AI-friendly hardware and Windows changes

Trump's AI Science Push Gets $100 Million Boost From a Computing Power Donation

AMD To Bring FSR4 To Gaming Handhelds By End Of 2026

Arista Announces Rack-Scale Architectures for Scale-Up and Scale-Out AI Fabrics

HPE Launches Four New AMD-Powered Servers as Part of Its ProLiant Gen13 Portfolio

ASUS Zenbook 14 (UX3480) Philippines Launch: New Colors, Specs, and Price

EURETINA: PulseSight Therapeutics to Present Results of Phase 1 clinical trial of PST-611 treatment for dry AMD/Geographic Atrophy (GA)

1 Articles

1 Articles

EURETINA: PulseSight Therapeutics to Present Results of Phase 1 clinical trial of PST-611 treatment for dry AMD/Geographic Atrophy (GA)

Coverage Details

Bias Distribution Too Big Arrow Icon

Factuality Info Icon

Ownership

More stories like this

Microsoft event debuts new AI-friendly hardware and Windows changes

Trump's AI Science Push Gets $100 Million Boost From a Computing Power Donation

AMD To Bring FSR4 To Gaming Handhelds By End Of 2026

Arista Announces Rack-Scale Architectures for Scale-Up and Scale-Out AI Fabrics

HPE Launches Four New AMD-Powered Servers as Part of Its ProLiant Gen13 Portfolio

ASUS Zenbook 14 (UX3480) Philippines Launch: New Colors, Specs, and Price

Similar News Topics

Similar News Topics

More stories like this

Microsoft event debuts new AI-friendly hardware and Windows changes

Trump's AI Science Push Gets $100 Million Boost From a Computing Power Donation

AMD To Bring FSR4 To Gaming Handhelds By End Of 2026

Arista Announces Rack-Scale Architectures for Scale-Up and Scale-Out AI Fabrics

HPE Launches Four New AMD-Powered Servers as Part of Its ProLiant Gen13 Portfolio

ASUS Zenbook 14 (UX3480) Philippines Launch: New Colors, Specs, and Price

Bias Distribution

Factuality